Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1-Reference-Cited by-同舟云学术

Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1

Published:2004-11-01 Issue:21 Volume:61 Page:2272-2279
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Kenna George A.¹,McGeary John E.²,Swift Robert M.²

Affiliation:

1. Center for Alcohol and Addiction Studies (CAAS), Brown University, Providence, RI, and Clinical Pharmacist, Kent County Memorial Hospital, Warwick, RI

2. Providence VA Medical Center, Providence; Associate Director, CAAS; and Professor of Psychiatry, Brown Medical School, Providence

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/61/21/2272/28419802/ajhp2272.pdf

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metallofullerenol alleviates alcoholic liver damage via ROS clearance under static magnetic and electric fields;Free Radical Biology and Medicine;2024-08

2. Clinical and Safety Evaluation of Liv.52 in Alcoholic Liver Disease: A Review;Gastroenterology Insights;2022-11-13

3. Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review;Frontiers in Pharmacology;2022-10-03

4. Role of the treatment environment in the effects of aripiprazole on ethanol-induced behavioral sensitization and conditioned place preference in female mice;Drug and Alcohol Dependence;2020-03

5. Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision;The World Journal of Biological Psychiatry;2016-12-23